Ocular gelling microspheres: In vitro precorneal retention time and drug permeation through reconstituted corneal epithelium

Journal of Ocular Pharmacology and Therapeutics

Volumn 24, Issue 2, 2008, Pages 186-196

  Giannola, Libero I ^a,b   De Caro, Viviana ^a   Giandalia, Giulia ^a,b   Siragusa, Maria G ^a   Cordone, Lorenzo ^a,b  

^a UNIVERSITY OF PALERMO   (Italy)

^b INFM   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EYE DROPS; GELATIN; HYDROXYETHYLCELLULOSE; MICROSPHERE; NORFLOXACIN; SPAN; TREHALOSE; UNCLASSIFIED DRUG; VELODERM;

ADHESION; ARTICLE; CONTROLLED STUDY; CORNEA EPITHELIUM; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; DRUG RETENTION; EMULSION; ENCAPSULATION; EVAPORATION; FLUORESCENCE; HUMAN; HUMAN CELL; IN VITRO STUDY; LACRIMAL FLUID; OPHTHALMIC DRUG DELIVERY; SWELLING;

ADHESIVENESS; ANTI-BACTERIAL AGENTS; AQUEOUS HUMOR; BIOLOGICAL AVAILABILITY; CELL LINE, TRANSFORMED; CELLULOSE; DELAYED-ACTION PREPARATIONS; EPITHELIUM, CORNEAL; GELATIN; GELS; HUMANS; MICROSPHERES; NORFLOXACIN; OPHTHALMIC SOLUTIONS; PERMEABILITY; TREHALOSE;

EID: 41349087809     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2007.0113     Document Type: Article

References (46)

1. Ceulemans, J., Vermeire, A., Adriaens, E., et al. Evaluation of a mucoadesive tablet for ocular use. J. Contr. Rel. 77:333-344, 2001.
2. Srividya, B., Cardoza, R.M., and Amin, P.D. Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system. J. Contr. Rel. 73:205-211, 2001.
3. Le Bourlais, C., Acar, L., Zia, H., et al. Ophthalmic drug delivery systems - recent advances. Prog. Ret. Eye Res. 17:33-58, 1998.
4. Law, S.L., Huang, K.J., and Chiang, C.H. Acyclovir-containing liposomes for potential ocular delivery. Corneal penetration and absorption. J. Contr. Rel. 63:135-140, 2000.
5. Lux, A., Maier, S., Dinslage, S., et al. A comparative bioavailability study of three conventional eye drops versus a single lyophilisate. Br. J. Ophthalmol. 87:436-440, 2003.
6. Hariprasad, S.M., Shah, G.K., Chi, J., et al. Determination of aqueous and vitreous concentration of moxifloxacin 0.5% after delivery via a dissolvable corneal collagen shield device. J. Cataract Refract. Surg. 31:2142-2146, 2005.
7. Gurtler, F., Kaltsatos, V., Boisramé, V., et al. Long-acting soluble bioadhesive oftalmic drug. Insert containing gentamicin for veterinary use: Optimization and clinical investigation. J. Contr. Rel. 33:231-236, 1995.
8. Lin, H.R., and Sung, K.C. Carbopol/pluronic phase change solutions for ophthalmic drug delivery. J. Contr. Rel. 69:379-388, 2000.
9. Dinslage, S., Diestelhorst, M., Weichselbaum, A., et al. Lyophilisates for drug delivery in ophthalmology. Pharmacokinetics of fluorescein in the human anterior segment. Br. J. Ophthalmol. 86:1114-1117, 2002.
10. Li, J., and Xu, Z. Physical characterisation of a chitosan-based hydrogel delivery system. J. Pharm. Sci. 91:1669-1677, 2002.
11. Ludwig, A. The use of mucoadhesive polymers in ocular drug delivery. Adv. Drug Deliv. Rev. 57:1595-1639, 2005.
12. Lee, J.W., Park, J.H., and Robinson, J.R. Bioadhesive-based dosage forms: The next generation. J. Pharm. Sci. 89:850-866, 2000.
13. Patel, G.M., Chuang, A.Z., Kiang, E., et al. Epithelial heating rates with topical ciprofloxacin, ofloxacin, and ofloxacin with artificial tears after photorefractive keratectomy. J. Cataract Refract. Surg. 26:690-694:2000.
14. Physician's Desk Reference, 58th ed. PDR® Electronic Library, Greenwood Village, CL: Thomson Micromedex, 2004.
15. Gipson, I.K. Distribution of mucins at the ocular surface. Exp. Eye Res. 78:379-388, 2004.
16. Argüeso, P., and Gipson, I.K. Epithelial mucins of the ocular surface: Structure biosynthesis and function. Exp. Eye Res. 73:281-289, 2001.
17. Matsuo, T., Tsuchida, Y., and Morimoto, N. Trehalose eye drops in the treatment of dry eye syndrome. Ophthalmology 109:2024-2029, 2002.
18. Matsuo, T. Trehalose versus hyaluronan or cellulose in eyedrops for the treatment of dry eye. Jpn. J. Ophthalmol. 48:321-327, 2004.
19. Crowe, J.H., Hoekstra, F.A., and Crowe, L.M. Anhydrobiosis. Ann. Rev. Physiol. 54:579-599, 1992.
20. Chiantia, S., Giannola, L.I., and Cordone, L. Lipid phase transition in saccaharide-coated cholate-containing liposomes: Coupling to the surrounding matrix. Langmuir 21:4108-4116, 2005.
21. Crowe, L.M., Reid, D.S., and Crowe, J.H. Is trehalose special for preserving dry biomaterials? Biophys. J. 71:2087-2093, 1996.
22. Giuffrida, S., Cottone, G., Librizzi, F., et al. Coupling between the thermal evolution of heme pocket and external matrix structure in trehalose coated carboxymyoglobin. J. Phys. Chem. B. 107:13211-13217, 2003.
23. Pereira, C.S., Lins, R.D., Chandrasekhar, I., et al. Interaction of the disaccharide trehalose with a phospholipid bilayer: A molecular dynamics study. Biophys. J. 86: 2273-2285, 2004.
24. Hornof, M., Toropainen, E., and Urtti, A. Cell culture models of the ocular barriers. Eur. J. Pharm. Biopharm. 60:207-225, 2005.
25. Firestone, B.A., Dickason, M.A., and Tran, T. Solubility characteristics of three fluoroquinolone ophthalmic solutions in an in vitro tear model. Int. J. Pharm. 164:119-128, 1998.
26. Nguyen, D.H., Beuerman, R.W., De Wever, B., et al. Three-dimensional construct of the human corneal epithelium for in vitro toxicology. In: Alternative Toxicological Methods. Salem, H., and Katz, S.A., Eds. CRC Press, Boca Raton, FL. 2003:147-159.
27. Gipson, I.K., Spurr-Michaud, S., Argüeso, P., et al. Mucin gene expression in immortalized human corneal - limbal and conjunctival epithelial cell lines. Invest. Ophthalmol. Vis. Sci. 44:2493-2506, 2003.
28. Reichl, S., Döhring, S., Bednarz, J., et al. Human cornea construct HCC-an alternative for in vitro permeation studies? A comparison with human donor corneas. Eur. J. Pharm. Biopharm. 60:305-308, 2005.
29. Ranta, V., Laavola, M., Toropainen, E., et al. Ocular pharmacokinetic modeling using corneal absorption and desorption rates from in vitro permeation experiments with cultured corneal epithelial cells. Pharm. Res. 20:1409-1416, 2003
30. Bartolotta, A., Campisi, M., D'Oca, M.C., et al. Effects of gamma irradiation on trehalose-hydroxyethylcellulose microspheres loaded with vancomycin. Eur. J. Pharm. Biopharm. 59:139-146, 2005.
31. Giannola, L.I., De Caro, V., Adragna, E., et al. A new delivery sysetm of antibiotics in the treatment of burn wounds. Ann. Burns Fire Disasters XII:14-19, 1999.
32. Giandalia, G., De Caro, V., Cordone, L., et al. Trehalose- hydroxyethylcellulose microspheres containing vancomycin for topical drug delivery. Eur. J. Pharm. Biopharm. 52:83-89, 2001.
33. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Meth. 65:55-63, 1983.
34. Vergnaud, J.M. Liquid transport controlled release processes in polymeric material: Applications to oral dosage forms. Int. J. Pharm. 90:89-94, 1993.
35. Korsmeyer, R.W., Gurny, R., Doelker, E., et al. Mechanisms of solute release from porous hydrophilic polymers. Int. J. Pharm. 15:25-35, 1983.
36. Peppas, N.A., and Sahlin, J.J. A simple equation for description of solute release. III. Coupling of diffusion and relaxation. Int. J. Pharm. 57:169-172, 1989.
37. Baumgartner, S., Kristl, J., and Peppas, N.A. Network structure of cellulose ethers used in pharmaceutical applications during swelling and at equi-librium. Pharm. Res. 8:1084-1090, 2002.
38. Wang, J., Tauchi, Y., Deguchi, Y., et al. Positively charged gelatin microspheres as gastric mucoadhesive drug delivery system for eradication of H. pylori. Drug Deliv. 7:237-243, 2000.
39. Negvesky, G.J., Butrus, S.I., Abifarah, H.A., et al. Ocular Gelfoam disc-applicator for pupillary dilatation in humans. J. Ocul. Pharmacol. Ther. 16:311-315, 2000.
40. Sintzel, M.B., Bernatchez, S.F., Tabatabay, C., et al. Biomaterials in ophtalmic drug delivery. Eur. J. Pharm. Biopharm. 42:358-374, 1996.
41. Vandervoort, J., and Ludwig, A. Preparation and evaluation of drug-loaded gelatin nanoparticles for topical ophthalmic use. Eur. J. Pharm. Biopharm. 57:251-261, 2004.
42. Giannola, L.I., De Caro, V., Giandalia, G., et al. Diffusion of naltrexone across reconstituted human oral epithelium and histomorphological features. Eur. J. Pharm. Biopharm. 65:238-246, 2007.
43. Wang, Y., Zhang, J., Yi, X., et al. Activation of ERK1/2 MAP kinase pathway induces tight junction disruption in human corneal epithelial cells. Exp. Eye Res. 78:125-136, 2004,
44. Toropainen, E., Ranta, V., Talvitie, A., et al. Culture model of human corneal epithelium for prediction of ocular drug absorption. Invest. Ophthalmol. Vis. Sci. 42:2942-2948, 2001.
45. Rodriguez, I.C., Cereo, A., and Salem, I.I. Sistemas de liberacion bioadhesivos (Bioadhesive delivery systems). Ars. Pharm. 41:115-128, 2000.
46. Vasir, J.K., Tambwekar, K., and Garg, S. Bioadhesive microspheres as a controlled drug delivery system. Int. J. Pharm. 255:13-32, 2003.